Factors like starting weight, metabolic health, diet, physical activity, and medication adherence all play a role
Instead of titrating to the full doses recommended for obesity treatment (e.g., semaglutide 2.4 mg weekly or tirzepatide up to 15 mg), microdosing involves starting and staying at much lower doses sometimes as low as 0.1 to 0.25 mg per week for semaglutide or even intermittent use
Research suggests it could play a role in managing nerve damage symptoms, especially when patients have a deficiency or a surplus of vitamin B6
But in the short time theyve been on the market, theyve demonstrated some serious issues that require further examination and study, specifically around how they are used, and how they affect overall health
Interestingly, the superiority analyses showed heterogeneous results among these trials